We are live on ! Find out more
JDR

Jay D. Rosenbaum Portfolio holdings

AUM $6.69M
1-Year Est. Return 4.68%
This Fund
S&P 500
This Quarter Est. Return
+2.47%
1 Year Est. Return
+4.68%
3 Year Est. Return
+12.92%
5 Year Est. Return
+74.65%
10 Year Est. Return
+173.05%
AUM
$52.7M
AUM Growth
-$116K
Cap. Flow
-$1.06M
Cap. Flow %
-2.02%
Top 10 Hldgs %
39.06%
Holding
52
New
1
Increased
13
Reduced
31
Closed
2

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$419K
2
LLY icon
Eli Lilly
LLY
+$208K
3
EW icon
Edwards Lifesciences
EW
+$114K
4
INTC icon
Intel
INTC
+$112K
5
SYK icon
Stryker
SYK
+$102K

Sector Composition

Rank Sector Weight
1 Healthcare 23.39%
2 Technology 21.49%
3 Financials 11.83%
4 Industrials 9.46%
5 Consumer Staples 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
51
Biogen
BIIB
$30.7B
-1,771
Closed -$419K
LLY icon
52
Eli Lilly
LLY
$1.09T
-1,600
Closed -$208K

Similar funds

Jay D. Rosenbaum's Q2 2019 Portfolio in Review

As of Q2 2019, Jay D. Rosenbaum held 52 positions worth $52.7M, down 0.22% from $52.8M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Jay D. Rosenbaum's Q2 2019 filing shows 1 new, 13 increased, 31 reduced and 2 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 770 shares worth $227K. The largest sale was Biogen, an estimated $419K.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Financials.

  • Jay D. Rosenbaum's largest Q2 2019 buy was State Street SPDR S&P 500 ETF Trust: 770 shares worth $227K.
  • Jay D. Rosenbaum added most to Amazon in Q2 2019, an estimated $85.7K increase.
  • Jay D. Rosenbaum's biggest Q2 2019 reduction was Edwards Lifesciences, cutting an estimated $114K.
  • Jay D. Rosenbaum fully exited Biogen in Q2 2019, selling an estimated $419K.
  • Jay D. Rosenbaum's ten largest holdings make up 39% of its $52.7M portfolio in Q2 2019.
  • Jay D. Rosenbaum opened 1 new position and closed 2 in Q2 2019.
  • Jay D. Rosenbaum's portfolio value fell 0.22% quarter-over-quarter to $52.7M.

Based on Jay D. Rosenbaum's 13F filing for Q2 2019, filed 1 Aug 2019.